Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of oral Navelbine as monotherapy in hormone receptor-positive breast cancer with bone metastases after hormone therapy
2009-014497-18Phase 2Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vinorelbine in breast cancer and bone metastases, sponsored by Pierre Fabre Laboratories. Primary endpoint: Progression-free survival. Started Nov 2009; status: completed.
02
Drugs
vinorelbine
03
Conditions
breast cancerbone metastases
Beyond the preview
Go deeper on 2009-014497-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014497-18.